SL
NGNE icon

Siren LLC’s Neurogene NGNE Stock Holding History

Siren LLC’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-175,898
Closed -$7.38M – 123
2024
Q3 		$7.38M Buy
+175,898
New +$6.82M 0.37% 52

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Siren LLC's NGNE Position: Q4 2024 in Review

Siren LLC sold out of Neurogene (NGNE) in Q4 2024, closing a stake of 175,898 shares — an estimated $7.38M sold.

Siren LLC first reported a position in NGNE in Q3 2024 and held it in 1 quarter. The position peaked at $7.38M in Q3 2024. 88 funds tracked by Wall St. Rank hold NGNE as of Q4 2024.

  • Siren LLC reported no remaining Neurogene position as of Q4 2024 after selling out during the quarter.
  • Siren LLC sold 175,898 Neurogene shares in Q4 2024, an estimated $7.38M.
  • Siren LLC first reported a position in Neurogene in Q3 2024 and held it in 1 quarter.
  • Siren LLC's Neurogene position peaked at $7.38M in Q3 2024.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q4 2024.

Based on Siren LLC's 13F filing for Q4 2024, filed 14 Feb 2025.